1,646
Views
42
CrossRef citations to date
0
Altmetric
Research Article

Normal liver tissue sparing by intensity-modulated proton stereotactic body radiotherapy for solitary liver tumours

, , , , &
Pages 823-828 | Received 30 Apr 2011, Accepted 18 May 2011, Published online: 18 Jul 2011

Figures & data

Table I. Constraints to targets and organs at risk.

Figure 1. Patient with solitary liver metastasis (CTV = 84 cm3) planned with IMRT (left) and IMPT (right). Threshold for dose colour wash is 15 Gy. Red and purple lines indicate CTV and PTV, respectively.

Figure 1. Patient with solitary liver metastasis (CTV = 84 cm3) planned with IMRT (left) and IMPT (right). Threshold for dose colour wash is 15 Gy. Red and purple lines indicate CTV and PTV, respectively.

Figure 2. Mean DVHs for normal liver (excluding CTV) for 10 patients with solitary liver metastasis planned with IMRT and IMPT. The prescribed dose for both plans was 16.75 Gy × 3 (level D).

Figure 2. Mean DVHs for normal liver (excluding CTV) for 10 patients with solitary liver metastasis planned with IMRT and IMPT. The prescribed dose for both plans was 16.75 Gy × 3 (level D).

Figure 3. Volume of spared normal liver (CTV excluded) receiving a dose lower than 15 Gy (VD < 15Gy) plotted according to the volume of the CTV. The prescribed dose for both plans in this figure was 16.75 Gy × 3 (level D).

Figure 3. Volume of spared normal liver (CTV excluded) receiving a dose lower than 15 Gy (VD < 15Gy) plotted according to the volume of the CTV. The prescribed dose for both plans in this figure was 16.75 Gy × 3 (level D).

Figure 4. Mean dose (Dmean) to the normal liver (CTV excluded) plotted according to volume of the CTV. The prescribed dose for both plans in this figure was 16.75 Gy × 3 (level D).

Figure 4. Mean dose (Dmean) to the normal liver (CTV excluded) plotted according to volume of the CTV. The prescribed dose for both plans in this figure was 16.75 Gy × 3 (level D).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.